Klacid P125 & P250 125mg / 5ml. 250mg / 5ml Granules
PDF Leaflet Revision Date: 7 July 2006
Clinical Summary
Quick overview from the medicine insert
Indication
Treatment of infections due to susceptible organisms.
Dosage (summary)
Children: 7.5 mg/kg twice daily; max 500 mg twice daily.
Onset of Action / Duration
Onset: 2.5 hours, Duration: 3.2 hours
Special Populations
- Renal impairment
- Hepatic impairment
Pregnancy & Breastfeeding
Safety not established; excreted in breast milk.
Key Drug Interactions
- Warfarin
- Colchicine
- CYP3A substrates
Contraindications
- Hypersensitivity to macrolides
- Concomitant use with terfenadine
Common side effects
- Diarrhoea
- Vomiting
- Abdominal pain
- Rash
Counselling Points
- Take with or without food
- Monitor for signs of toxicity
- Avoid in severe renal impairment
Serious warnings
- Pseudomembranous colitis
- Colchicine toxicity
- QT prolongation
Important Disclaimer
The Klacid P125 & P250 125mg / 5ml. 250mg / 5ml Granules professional information leaflet below is the property of Abbott Laboratories Sa and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
